Reliance Industries-powered Strand Life Sciences unveils …
1 day ago · Strand Life Sciences, a subsidiary of Reliance Industries, has introduced CancerSpot, a blood-based test for early cancer detection. It employs methylation profiling technology to identify tumor DNA fragments from blood samples. The test is tailored using data from Indian cohorts, making it relevant globally. This initiative aligns with Reliance's goal of advancing healthcare through genomics.
Reliance subsidiary Strand Life Sciences launches blood-based …
2 days ago · Strand Life Sciences, a subsidiary of Reliance Industries Limited, has launched a novel blood-based test for early detection of multiple cancers. Called CancerSpot, the test uses the latest ...
News - Strand Life Sciences
Palisade Bio Enters into Strategic Collaboration with Strand Life Sciences to Advance Precision Medicine Approach
Reliance subsidiary Strand Life Sciences launches tests for early ...
1 day ago · Speaking at the grand opening of Strand’s new genomics diagnostics & research centre here, Dr Ramesh Hariharan, CEO and co-founder, Strand Life Sciences, said, “Early warning is the key to battle cancer ─ and win it. We are proud to launch an accessible early cancer detection test that will enable people to stay ahead of cancer.
Strand Life Sciences, a Reliance subsidiary, Launches Pioneering …
1 day ago · Leading genomics and bioinformatics company Strand Life Sciences, a subsidiary of Reliance Industries Limited, has launched a novel blood-based test for early detection of multiple cancers. Called ...
Reliance Industries acquires 2.28 cr shares of Strand Life Sciences for ...
Sep 3, 2021 · Reliance Strategic Business Ventures Limited (RSBVL), a wholly-owned subsidiary of Reliance Industries Limited, has acquired 2,28,42,654 equity shares of Rs 10 each of Strand Life Sciences...
Palisade Bio Enters into Strategic Collaboration with Strand Life ...
The collaboration with Strand Life Sciences provides Palisade Bio access to advanced bioinformatics tools vital for understanding complex disease pathways and predicting responses to PDE4...
Strand Life Sciences Launches CancerSpot: A Blood-Based Test …
1 day ago · Strand Life Sciences bioinformatics company and a subsidiary of Reliance Industries Limited have introduced CancerSpot, a revolutionary blood-based test for the early detection of multiple cancers. Employing state-of-the-art methylation profiling technology, CancerSpot identifies DNA methylation signatures of tumor DNA from a simple blood sample, offering a proactive and accessible approach to ...
SOPHiA GENETICS and Strand Life Sciences Announce New …
Apr 2, 2024 · Boston, MA and Rolle, Switzerland, April 4, 2024 – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced a strategic partnership with Strand Life Sciences, a pioneer in bioinformatics and diagnostics, to deliver innovative solutions that will fuel the use ...
Palisade Bio Provides Update on Advancement of its Strategic ...
Jun 21, 2024 · Under the collaboration through an extensive analysis of transcriptomics datasets and clinical biomarkers, Palisade Bio and Strand have identified promising PDE4-related biomarkers associated with UC pathology, providing valuable insights for …